Diagnostics and Tools March 2024

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• Invicro, LLC was acquired by Calyx Services Inc.
• Telix Pharmaceuticals Limited (ASX:TLX) announced its acquisition of ARTMS, INC.
• Zephyr AI, Inc. closed a $111.4MM Series A Financing, led by Eli Lilly and, Revolution Growth, EPIQ Capital Group, LLC